172 related articles for article (PubMed ID: 38798589)
1. Cell-free RNA Liquid Biopsy to Monitor Hematopoietic Stem Cell Transplantation.
Loy C; Cheng MP; Gonzalez-Bocco IH; Lenz J; Belcher E; Bliss A; Eweis-LaBolle D; Chu T; Ritz J; De Vlaminck I
medRxiv; 2024 May; ():. PubMed ID: 38798589
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.
Shinohara A; Oshima K; Fuji S; Umeda K; Kako S; Kurokawa M; Tsukada N; Kasai M; Kondo T; Hashii Y; Nakamae H; Ikegame K; Kosaka Y; Shimada A; Nawa Y; Makoto Y; Yoshiko A; Fukuda T; Tanaka J; Ogata M
Biol Blood Marrow Transplant; 2020 Jan; 26(1):66-75. PubMed ID: 31494230
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.
Cheng AP; Cheng MP; Loy CJ; Lenz JS; Chen K; Smalling S; Burnham P; Timblin KM; Orejas JL; Silverman E; Polak P; Marty FM; Ritz J; De Vlaminck I
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058359
[No Abstract] [Full Text] [Related]
4. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.
Yetmar ZA; Thoendel MJ; Bosch W; Seville MT; Hogan WJ; Beam E
Transplant Cell Ther; 2023 Mar; 29(3):206.e1-206.e7. PubMed ID: 36526261
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
8. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
9. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
[TBL] [Abstract][Full Text] [Related]
11. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
12. Improved NK Cell Recovery Following Use of PTCy or Treg Expanded Donors in Experimental MHC-Matched Allogeneic HSCT.
Wolf D; Barreras H; Copsel SN; Komanduri KV; Levy RB
Transplant Cell Ther; 2022 Jun; 28(6):303.e1-303.e7. PubMed ID: 35302008
[TBL] [Abstract][Full Text] [Related]
13. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
[TBL] [Abstract][Full Text] [Related]
14. Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J; Baumann CK; Lobmeyr E; Grafeneder J; Ettl F; Eibensteiner F; Rabitsch W; Mitterbauer M; Knaus HA; Wohlfarth P
Transplant Cell Ther; 2023 May; 29(5):321.e1-321.e9. PubMed ID: 36842484
[TBL] [Abstract][Full Text] [Related]
15. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
16. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
17. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
[TBL] [Abstract][Full Text] [Related]
18. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
19. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
